AGX affiliate files Form 144 for common stock sales

Argan, Inc. (AGX) affiliate submitted a Form 144 notice regarding proposed transactions in Common Stock.

Rhea-AI Filing Summary

Argan, Inc. (AGX) affiliate submitted a Form 144 notice regarding proposed transactions in Common Stock. The filing lists prior grants including 2,592 shares (time-based restricted stock, 12/14/2024) and 6,964 shares (equity grant, 12/20/2024). It also records sales of 2,700 shares on 01/20/2026 and 5,000 shares on 01/27/2026 with proceeds shown in the filing.

Insights

Corporate Governance Analyst

Form 144 notifies the market of affiliate stock transactions; filings are routine notices.

The record lists compensation-related issuances (time-based restricted stock and equity grant) dated 12/14/2024 and 12/20/2024. It also shows two sales by John R. Jeffrey, Jr.: 2,700 shares on 01/20/2026 and 5,000 shares on 01/27/2026, with dollar amounts reported alongside each sale.

These notices document affiliate liquidity activity rather than operational results; cash‑flow treatment is indicated by the listed proceeds in the sale rows. Subsequent SEC filings may show whether additional planned sales proceed under the Form 144 notice.

Key Figures

Time-Based Restricted Stock Issuance: 2,592 shares Equity Grant: 6,964 shares Sale by John R. Jeffrey, Jr.: 2,700 shares +3 more

6 metrics

Time-Based Restricted Stock Issuance 2,592 shares dated <date>12/14/2024</date>

Equity Grant 6,964 shares dated <date>12/20/2024</date>

Sale by John R. Jeffrey, Jr. 2,700 shares sold on <date>01/20/2026</date>

Sale by John R. Jeffrey, Jr. 5,000 shares sold on <date>01/27/2026</date>

Proceeds from 01/20/2026 sale $1,027,620 listed adjacent to the 2,700-share sale

Proceeds from 01/27/2026 sale $1,803,900 listed adjacent to the 5,000-share sale

Key Terms

Form 144, Time-Based Restricted Stock Issuance, Equity Grant, Option Exercise

4 terms

Form 144 regulatory

"144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Time-Based Restricted Stock Issuance financial

"Common Stock | 12/14/2024 | Time-Based Restricted Stock Issuance"

Equity Grant financial

"Common Stock | 12/20/2024 | EQUITY GRANT"

Option Exercise financial

"12/20/2024 | OPTION EXERCISE"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does AGX's Form 144 report?

It reports proposed and recent affiliate transactions in AGX common stock. The filing lists grants of 2,592 and 6,964 shares and two sales of 2,700 and 5,000 shares in January 2026.

Who is the selling party in the AGX Form 144?

The filing identifies John R. Jeffrey, Jr. as the reporting person. The rows show his sales of 2,700 and 5,000 shares on 01/20/2026 and 01/27/2026, respectively.

Are the listed grants in AGX Form 144 compensation-related?

Yes; the filing labels a Time-Based Restricted Stock Issuance of 2,592 shares and an Equity Grant of 6,964 shares both dated in December 2024.

Do the Form 144 entries show sale proceeds for AGX transactions?

Yes; the sale rows include dollar figures next to the share sales. For example, the 2,700-share sale shows $1,027,620 and the 5,000-share sale shows $1,803,900 in the filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/31/2026 - 11:29 AM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001709914
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	ARGAN, INC.
SEC File Number	001-31756
Address of Issuer	4075 WILSON BOULEVARD SUITE 440 ARLINGTON VIRGINIA 22203
Phone	3013150027
Name of Person for Whose Account the Securities are To Be Sold	John Ronald Jeffrey Jr.
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Charles Schwab & Co. Inc. 3000 Schwab Way Westlake TX 76262	4556	2386296.12	13945962	03/31/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	12/14/2024	Time-Based Restricted Stock Issuance	Issuer			2592	12/14/2024	N/A
Common Stock	12/20/2024	EQUITY GRANT	Issuer			6964	12/20/2024	OPTION EXERCISE

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
John R. Jeffrey, Jr. c/o Argan, Inc. 4075 Wilson Blvd, Suite 440 Arlington VA 22203	Common Stock	01/20/2026	2700	1027620
John R. Jeffrey, Jr. c/o Argan, Inc. 4075 Wilson Blvd, Suite 440 Arlington VA 22203	Common Stock	01/27/2026	5000	1803900

144: Remarks and Signature

Remarks
Date of Notice	03/31/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ John R. Jeffrey, Jr.
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)